E06-00-0711
Nellcor DS100A versus Honeywell Healthcare Solutions E06-00-0711:
Honeywell Healthcare Solutions XRL SpO2 compatibility list, 2026-04 sensor section; cover revision 1 valid 2026-04-02. Official download byte-for-byte matches reviewed PDF. Original SENSOR brand/code Nellcor DS100A; Honeywell order code E06-00-0711, sensor name R-3212-9 Nellcor; type SoftTip® large; cable 0,9 m; plug code C05. Selected only source rows marked available, direct connection, with no required original accessory. Available is the document status, not a live stock or lifecycle promise. DEVICE-SPECIFIC COMPATIBILITY REFERENCE ONLY: limited to these exact source-listed monitor manufacturer/model contexts: Baxter / Explorer/ Monarch; Biosys Co., LTD / BPM-200; Biosys Co., LTD / Vital Sign Monitor SENTRY; Covidien / N-10; Covidien / N-180; Covidien / N-190; Covidien / N-20; Covidien / N-30; Covidien / NPB-190; Covidien / NPB-195; Covidien / NPB-3910; Covidien / NPB-3920; Covidien / NPB-3930; Covidien / NPB-3940; Covidien / NPB-4000; Covidien / NPB-75; Datascope / Expert (Nellcor® SpO2); Datascope / Passport (Nellcor® SpO2); Fukuda Denshi / DS-5100E; Fukuda Denshi / DS-5300W. This is not a monitor-to-sensor equivalence, a generic connector interchange, an approval for other monitor models or an independent clinical/regulatory certification. Confirm current Honeywell instructions, monitor technology and software compatibility, sensor type/patient size, reusable/disposable status, wavelength/calibration, electrical interface, alarm/measurement performance, cleaning/sterilization and approvals with the device manufacturer before use. Patient-site/size variants are not interchangeable merely because the original article is the same. Nellcor references are restricted to the guide's non-OxiMax technology context where stated; do not apply to OxiMax systems. DS100A and DS-100A spellings remain distinct as printed; no punctuation or suffix variants inferred. Original recommendation is original sensor to Honeywell sensor within the stated device contexts; reverse discovery does not make it a symmetric clinical substitute. Manufacturer suitability confirmation and application testing remain required. PDF pages: 9, 31, 32, 56, 61, 63, 65, 70, 75, 77, 82, 84, 86, 89, 91, 93, 98, 100, 127, 129.